Haohai Biological Technology (06826.HK) reported net profit attributable to shareholders of approximately RMB 163 million for the first three quarters, a year-on-year decrease of 46.53%.

Zhitong Finance APP News, Haohai Biological Technology (06826.HK) announced its results for the first three quarters of 2026, with operating revenue of approximately RMB 1.71 billion, a year-on-year decrease of 9.93%; net profit attributable to shareholders of the listed company of approximately RMB 163 million, a year-on-year decrease of 46.53%; basic earnings per share of RMB 0.71.